that encourage the generation of antibodies that can protect against pathogenic bacteria. During the COVID-19 pandemic Doores studied the levels of antibodies in patients who had suffered from COVID-19 in Guy's and St Thomas' NHS Foundation Trust. Her research showed that while 60% of COVID-19 patients elicited a strong antibody response, only 17% of them retained this potency three months later. In some cases, patients entirely lost their antibody response. These results implied that immunity to COVID-19 might be short lived, and that people may become reinfected during a second wave of infection. Selected publications References External links Katie Doores at King's College London The Doores Lab Living people Year of birth missing (living people) Women biochemists British women chemists Alumni of the University of Oxford HIV vaccine research Academics of King's College London Scripps Research faculty COVID-19 researchers